Immunomic Therapeutics
Jennifer Onorato, ASQ CQA, currently serves as Associate Director of Quality Assurance at Immunomic Therapeutics, Inc., a position held since May 2022. Previous roles include Quality Assurance Manager at Charles River Laboratories and Senior Quality Assurance Specialist at Catalent Pharma Solutions. Jennifer has extensive experience in quality assurance within the biotechnology and pharmaceutical sectors, having also held positions such as Quality Assurance Supervisor and QA Specialist at various divisions of Lonza, as well as Supervisor of Quality Assurance at Pharmaceutics International, Inc. Educational qualifications include a Bachelor of Science in Biology from the University of Maryland Baltimore County and an Associate of Science in Biology from Anne Arundel Community College. Expertise includes cell therapy technical transfer, internal and external audits, and cGMP manufacturing processes.
This person is not in any teams
This person is not in any offices
Immunomic Therapeutics
1 followers
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.